Bb5a31f81ClaimTraditional drug development relies on empirical trial-and-error screening processes rather than predictive computational modelingAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs trains computational models to predict molecular structures and interactions at experimental accuracyAgreeDisagree
Bb5a31f81ClaimAlphaFold's demonstration of protein structure prediction served as the proof of concept that led to the founding of Isomorphic LabsAgreeDisagree
Bb5a31f81ClaimMost candidate drugs fail during human clinical trials rather than during preclinical in-vitro researchAgreeDisagree
Bb5a31f81ClaimAutomated wet laboratories and robotic platforms remain constrained by physical reaction rates and cell culturing timesAgreeDisagree
Bb5a31f81ClaimDrug regulatory frameworks historically mandated testing candidate molecules on rats and other animals before human clinical trialsAgreeDisagree
Bb5a31f81ClaimPatients facing late-stage terminal cancers typically possess a higher tolerance for treatment risk than patients treated for chronic low-level inflammationAgreeDisagree
Bb5a31f81ClaimTraditional pharmaceutical research typically treats each drug program as a bespoke project, limiting transferable learnings to subsequent programsAgreeDisagree
Bb5a31f81ClaimDetermining protein structures through X-ray crystallography traditionally requires months or years of laboratory experimentsAgreeDisagree
Bb5a31f81ClaimIn-vitro laboratory endpoints can be combined with computational predictive models and synthetic human tissues to assess clinical toxicityAgreeDisagree
Bb5a31f81ClaimData repositories from historical pharmaceutical research often reflect biased sampling that limits machine learning model generalizationAgreeDisagree
Bb5a31f81ClaimThe RAS protein family has been studied as a driver of cancer in biological research since the early 1990sAgreeDisagree
Bb5a31f81ClaimIsomorphic Labs relies on physical laboratory experiments primarily for hypothesis validation rather than iterative discoveryAgreeDisagree
Bb5a31f81ClaimAlphaGenome increased genomic prediction resolution from Enformer's 128 base pairs down to single base-pair resolutionAgreeDisagree
Bb5a31f81ClaimResearchers at the Francis Crick Institute experimentally validated that a non-coding variant regulates a target gene situated 290,000 base pairs awayAgreeDisagree
Bb5a31f81ClaimAlphaGenome Atlas precomputed variant effect predictions across all 9 billion possible single-nucleotide mutations in the human genomeAgreeDisagree
Bb5a31f81ClaimIn 2025, Google DeepMind unveiled AlphaGenome to predict the function of non-coding DNA across whole tissuesAgreeDisagree
Bb5a31f81ClaimAlphaGenome 2 allows external researchers to input custom cell-type data to generate variant effect predictions without fine-tuning the modelAgreeDisagree
Bb5a31f81ClaimAlphaGenome 2 evaluates variant impacts at the individual cell-type level rather than aggregate bulk tissue measurementsAgreeDisagree
Bb5a31f81ClaimA study by Michael Goran of California infants enrolled in WIC found that those fed corn syrup formula had higher obesity rates at ages two, three, and four compared to those fed lactose formulaAgreeDisagree